Kaifeng Pharmaceutical (GROUP) Co., Ltd.
-
Founded in:
2003-09-26 -
Country:
China -
Address:
No. 1, Yunan Street, Kaifeng City -
Tax NO.:
914102007551588773 -
Registered Funds:
204.568562 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Gentamicin sulfate |
Aminoglycoside antibiotics have good antibacterial effects on various Gram-negative and Gram-positive bacteria. Their mechanism of action is to bind to the 30S subunit of bacterial ribosomes and inhibit the synthesis of bacterial proteins.
More
Aminoglycoside antibiotics have good antibacterial effects on various Gram-negative and Gram-positive bacteria. Their mechanism of action is to bind to the 30S subunit of bacterial ribosomes and inhibit the synthesis of bacterial proteins. |
1405-41-0 | 29 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| 1,2,3,5/4,6-cyclohexane hexane nicotine ester |
A mild peripheral vasodilator with the pharmacological effects of niacin and inositol, it can lower blood lipids; the vasodilator effect is mild and long-lasting, without the side effects of niacin flushing and stomach discomfort; it selectively dilates blood vessels in diseased areas and areas sensitive to cold stimulation; it has the effects of dissolving blood clots, anti-coagulation, anti-fatty liver, and reducing capillary fragility.
More
A mild peripheral vasodilator with the pharmacological effects of niacin and inositol, it can lower blood lipids; the vasodilator effect is mild and long-lasting, without the side effects of niacin flushing and stomach discomfort; it selectively dilates blood vessels in diseased areas and areas sensitive to cold stimulation; it has the effects of dissolving blood clots, anti-coagulation, anti-fatty liver, and reducing capillary fragility. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| 1,2,3,5/4,6-cyclohexane hexane nicotine ester |
This product is a mild peripheral vasodilator, which is gradually hydrolyzed into niacin and inositol in the body, so it has the pharmacological effects of both niacin and inositol, and has lipid-lowering effects. Its vasodilating effect is milder and more lasting than that of niacin, and it does not have side effects such as flushing and stomach discomfort after taking niacin. This product can selectively dilate blood vessels in lesions and sensitive areas stimulated by cold, while its dilating effect on normal blood vessels is weaker. In addition, it has the effects of dissolving blood clots, anticoagulation, anti-fatty liver, and reducing capillary fragility.
More
This product is a mild peripheral vasodilator, which is gradually hydrolyzed into niacin and inositol in the body, so it has the pharmacological effects of both niacin and inositol, and has lipid-lowering effects. Its vasodilating effect is milder and more lasting than that of niacin, and it does not have side effects such as flushing and stomach discomfort after taking niacin. This product can selectively dilate blood vessels in lesions and sensitive areas stimulated by cold, while its dilating effect on normal blood vessels is weaker. In addition, it has the effects of dissolving blood clots, anticoagulation, anti-fatty liver, and reducing capillary fragility. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Doxycycline hydrochloride |
Tetracycline antibiotics, broad-spectrum antibacterial agents, have bactericidal effects at high concentrations. It is sensitive to Rickettsia, Mycoplasma, Chlamydia, atypical mycobacteria, and spirochetes. It is more effective against Gram-positive bacteria than Gram-negative bacteria, but Enterococcus is resistant to it. Others such as Actinomycetes, Bacillus anthracis, Listeria monocytogenes, Clostridium, Nocardia, Vibrio, Brucella, Campylobacter, and Yersinia are sensitive to it. It has certain antibacterial activity against Neisseria gonorrhoeae, but penicillin-resistant Neisseria gonorrhoeae is resistant to it. Common clinical pathogens are seriously resistant to this product, including Gram-positive bacteria such as Staphylococcus and most Gram-negative bacilli.
More
Tetracycline antibiotics, broad-spectrum antibacterial agents, have bactericidal effects at high concentrations. It is sensitive to Rickettsia, Mycoplasma, Chlamydia, atypical mycobacteria, and spirochetes. It is more effective against Gram-positive bacteria than Gram-negative bacteria, but Enterococcus is resistant to it. Others such as Actinomycetes, Bacillus anthracis, Listeria monocytogenes, Clostridium, Nocardia, Vibrio, Brucella, Campylobacter, and Yersinia are sensitive to it. It has certain antibacterial activity against Neisseria gonorrhoeae, but penicillin-resistant Neisseria gonorrhoeae is resistant to it. Common clinical pathogens are seriously resistant to this product, including Gram-positive bacteria such as Staphylococcus and most Gram-negative bacilli. |
10592-13-9 | 13 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Doxycycline hydrochloride |
Tetracycline antibiotics, broad-spectrum antibacterial agents, have bactericidal effects at high concentrations. It is sensitive to Rickettsia, Mycoplasma, Chlamydia, atypical mycobacteria, and spirochetes. It is more effective against Gram-positive bacteria than Gram-negative bacteria, but Enterococcus is resistant to it. Others such as Actinomycetes, Bacillus anthracis, Listeria monocytogenes, Clostridium, Nocardia, Vibrio, Brucella, Campylobacter, and Yersinia are sensitive to it. It has certain antibacterial activity against Neisseria gonorrhoeae, but penicillin-resistant Neisseria gonorrhoeae is resistant to it. Common clinical pathogens are seriously resistant to this product, including Gram-positive bacteria such as Staphylococcus and most Gram-negative bacilli.
More
Tetracycline antibiotics, broad-spectrum antibacterial agents, have bactericidal effects at high concentrations. It is sensitive to Rickettsia, Mycoplasma, Chlamydia, atypical mycobacteria, and spirochetes. It is more effective against Gram-positive bacteria than Gram-negative bacteria, but Enterococcus is resistant to it. Others such as Actinomycetes, Bacillus anthracis, Listeria monocytogenes, Clostridium, Nocardia, Vibrio, Brucella, Campylobacter, and Yersinia are sensitive to it. It has certain antibacterial activity against Neisseria gonorrhoeae, but penicillin-resistant Neisseria gonorrhoeae is resistant to it. Common clinical pathogens are seriously resistant to this product, including Gram-positive bacteria such as Staphylococcus and most Gram-negative bacilli. |
10592-13-9 | 13 |